Precision BioSciences share price logo

Precision BioSciences

NASDAQ: DTIL

$7.78

-0.62

(-7.38%)

as on

Precision BioSciences Stock Performance

as on August 29, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $7.72
    $8.43
    downward going graph

    0.77%

    Downside

    8.35%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.53
    $9.62
    downward going graph

    54.63%

    Downside

    23.65%

    Upside

    downward going graph

Precision BioSciences share price movements today

Previous Close
$8.40
Open
$8.43
Volume
286.3K
Market Cap
$234.3M
Day's Low - High
$7.72 - $8.43
52 Week Low - High
$3.53 - $9.62

Precision BioSciences Historical Returns

1 Month Return
+ 17.15 %
3 Month Return
+ 21.39 %
1 Year Return
+ 67.33 %
3 Year Return
-47.66 %
5 Year Return
-97.58 %

Precision BioSciences Stock Fundamentals & Key Indicators

Check Precision BioSciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$234.3M

EPS (TTM)

-2.79

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.01

Industry PE ratio

-1.6366929133858268

PEG Ratio

-0.022142996591184648

EBITDA

-50.1M

Revenue (TTM)

45.1M

Profit Margin

100.00%

Return On Equity TTM

-91.60%

Precision BioSciences Stock Valuation

Track how Precision BioSciences P/E has moved over time to understand its valuation trends.

Precision BioSciences in the last 5 years

  • Overview

  • Trends

Lowest (-14.19x)

December 31, 2021

Industry (-1.64x)

December 31, 2025

Today (-1.17x)

December 31, 2025

Highest (3.63x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -1.17x

Precision BioSciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Precision BioSciences with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Precision BioSciences image
Precision BioSciences
BUY$234.3M-97.58%-3.01100.00%NA
Revolution Medicines image
Revolution Medicines
BUY$46.2B675.69%NA0.00%NA
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
BUY$138.7B173.88%31.9286.04%NA
Moderna image
Moderna
BUY$59.7B-62.65%-7.98-12.57%NA
Regeneron image
Regeneron
BUY$85.8B21.77%19.984.86%0.44%

Stock Returns calculator for Precision BioSciences Stock including INR - Dollar returns

The Precision BioSciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Precision BioSciences investment value today

Current value as on today

₹1,68,740

Returns

₹68,740

(+68.74%)

Returns from Precision BioSciences Stock

₹54,980 (+54.98%)

Dollar Impact

₹13,760 (+13.76%)

Analyst Recommendation on Precision BioSciences Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Precision BioSciences. Average target price of $29.4

Precision BioSciences Share Price Target

Get share price movements and forecasts by analysts on Precision BioSciences.

What analysts predicted

73.54%UPSIDE

Target Price

$29.4

Current Price

$7.78

Analyzed by

3 Analysts

Target

$29.40

Precision BioSciences target price $29.4, a slight upside of 73.54% compared to current price of $7.78. According to 3 analysts rating.

Indian Investors' Interest in Precision BioSciences Stock

Search interest for Precision BioSciences Stock has decreased by -39% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-39% versus previous 30 day period

Precision BioSciences Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
17
49
0
0
0
0
0
34
10
-
Gross Profit
17
49
0
0
0
0
0
34
10
-
Operating Income
-4
24
-21
-24
-22
-21
-20
12
-9
-19
EBITDA
10
34
-15
-16
-19
-22
-20
20
-17
-32
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
1
1
1
0
0
0
0
0
0
0
Income Before Tax
8
32
-16
-17
-20
-23
-21
19
-18
-32
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
8
32
-16
-17
-20
-23
-21
20
-18
-32
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
0.00%

Precision BioSciences Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
6
10
22
24
115
25
48
68
34
Gross Profit
6
10
22
24
115
25
48
68
34
Operating Income
-21
-47
-87
-109
-39
-62
-43
-26
-52
EBITDA
-20
-43
-87
-99
-20
-62
-32
13
-42
Interest Expense
-
-
0
-
0
1
2
1
1
Depreciation
1
2
5
9
10
9
8
4
2
Income Before Tax
-21
-46
-92
-109
-30
-72
-42
7
-46
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-21
-46
-92
-109
-30
-111
-61
7
-45
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%

Precision BioSciences Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
8
32
-16
-17
-20
-23
-21
20
-18
-32
Operating Cash Flow
-18
-14
-5
-18
-19
-20
-15
-11
-11
-13
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
40
0
3
5
10
5
1
77
0
-
Change in Cash
21
-14
-2
-12
-8
-14
-17
65
-11
-13

Precision BioSciences Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-21
-46
-92
-109
-30
-111
-61
7
-45
Operating Cash Flow
-24
-51
-73
-87
-10
-45
-84
-58
-65
Investing Cash Flow
-5
-15
-24
-5
-5
-3
5
0
0
Financing Cash Flow
0
107
175
1
70
94
5
50
95
Change in Cash
-30
40
77
-91
53
45
-72
-8
28

Mutual Funds that own Precision BioSciences Stock

Check out the Mutual Funds with significant holdings in Precision BioSciences.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.239976%
894284
Fidelity Concord Street Trust
0.678697%
187331
Meridian Fund Inc
0.649021%
179140
Jacob Funds Inc.
0.170602%
47089
RBC Funds Trust
0.144919%
40000
See all

Global Institutional Holdings in Precision BioSciences

Funds
Holdings
Vanguard
4.53%
Richard Driehaus
3.43%
iShares
3.1%
Fidelity
0.43%
Dimensional
0.16%
See all

Precision BioSciences News & Key Events

  • img

    Today's Timeline - 11 March

    Wed, 04:32 PM

    -

    Precision BioSciences receives two U.S. patent allowances for PBGENE-HBV program, enhancing intellectual property protection.

Insights on Precision BioSciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -30.9 Cr → 4.52 Cr (in ₹), with an average increase of 783.6% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, DTIL stock has moved up by 19.4%

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 68.90% to 69.00% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 83.93 Cr → 86.09 Cr (in ₹), with an average increase of 2.5% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Avanti Feeds Ltd has given 92.9% return, outperforming this stock by 113.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 19.0% return, outperforming this stock by 70.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Avanti Feeds Ltd has given 28.8% return, outperforming this stock by 40.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 472.8% return, outperforming this stock by 414.0%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 20.13M → -32.65M (in $), with an average decrease of 134.3% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 29.11% to 29.01% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 34.20M → 10.83M (in $), with an average decrease of 68.3% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, DTIL stock has moved down by -12.1%

About Precision BioSciences

Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits, as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; and PBGENE-DMD (Excision) for the treatment of Duchenne muscular dystrophy. In addition, the company develops PBGENE-3243 for the treatment of m.3243 associated mitochondrial diseases; and iECURE-OTC (Insertion) for ornithine transcarbamylase deficiency. It has collaboration agreements with TG Cell Therapy, Inc. to develop, manufacture, and commercialize azercabtagene zapreleucel for autoimmune diseases and other indications; and iECURE, Inc., an ARCUS-mediated targeted gene insertion. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.
OrganisationPrecision BioSciences
Headquarters302 East Pettigrew St., Durham, NC, United States, 27701
IndustryBiotechnology
CEOMr. Michael Amoroso
E-voting on sharesClick here to vote

Key Management of Precision BioSciences

Name

Title

Mr. Michael Amoroso

President, CEO & Director

Mr. John Alexander Kelly R.Ph.

Chief Operating Officer

Dr. Jefferson J. Smith Ph.D.

Co-Founder & Chief Research Officer

FAQs

What is Precision BioSciences share price today?

Precision BioSciences share price today is $7.78 as on at the close of the market. Precision BioSciences share today touched a day high of $8.43 and a low of $7.72.

What is the 52 week high and 52 week low for Precision BioSciences share?

Precision BioSciences share touched a 52 week high of $9.62 on and a 52 week low of $3.53 on . Precision BioSciences stock price today i.e. is closed at $7.78,which is 19.13% down from its 52 week high and 120.40% up from its 52 week low.

What is Precision BioSciences's market capitalisation today?

Precision BioSciences market capitalisation is $0.00T as on .

How to invest in Precision BioSciences Stock (DTIL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Precision BioSciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Precision BioSciences Shares that will get you 0.1928 shares as per Precision BioSciences share price of $7.78 per share as on August 29, 2026 at 8:45 am IST.

What is the minimum amount required to buy Precision BioSciences Stock (DTIL) from India?

Indian investors can start investing in Precision BioSciences (DTIL) shares with as little as ₹95.368 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.68 in Precision BioSciences stock (as per the Rupee-Dollar exchange rate as on ). Based on Precision BioSciences share’s latest price of $7.78 as on August 29, 2026 at 8:45 am IST, you will get 1.2853 shares of Precision BioSciences. Learn more about fractional shares .

What are the returns that Precision BioSciences has given to Indian investors in the last 5 years?

Precision BioSciences stock has given -97.58% share price returns and 30.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?